Skip to main content

Table 2 Provider anti-malarial treatment knowledge by outlet type

From: The malaria testing and treatment landscape in the southern Lao People’s Democratic Republic (PDR)

  Public health facility Community health worker Public sector total Private for-profit facility Pharmacy General retailer Private sector total
  %
(95% CI)
%
(95% CI)
%
(95% CI)
%
(95% CI)
%
(95% CI)
%
(95% CI)
%
(95% CI)
Proportion of providers who: N = 91 N = 164 N = 255 N = 58 N = 327 N = 30 N = 424
Correctly state the national first-line treatment for uncomplicated P. falciparum/vivax malaria, AL 89.5
(81.7, 94.2)
72.6
(64.7, 79.3)
77.9
(72.0, 82.9)
78.7
(63.8, 88.5)
49.5
(39.0, 60.0)
8.1
(2.7, 21.9)
40.4
(31.6, 49.8)
Correctly state the first-line (AL) dosing regimen for uncomplicated P. falciparum/vivax malaria for an adult 73.0
(60.7, 82.5)
51.3
(41.0, 61.5)
58.2
(49.6, 66.3)
66.4
(51.1, 78.8)
36.5
(28.0, 46.0)
6.1
(1.6, 20.6)
30.2
(23.1, 38.2)
  1. AL artemether–lumefantrine